Show simple item record

dc.contributor.authorHunter, Robin D
dc.contributor.authorCowie, Valerie J
dc.contributor.authorBlair, Val
dc.contributor.authorCole, Moya P
dc.date.accessioned2010-11-09T16:58:28Z
dc.date.available2010-11-09T16:58:28Z
dc.date.issued1986-01
dc.identifier.citationA clinical trial of two conceptually different radical radiotherapy treatments in stage III carcinoma of the cervix. 1986, 37 (1):23-7 Clin Radiolen
dc.identifier.issn0009-9260
dc.identifier.pmid3514074
dc.identifier.doi10.1016/S0009-9260(86)80157-X
dc.identifier.urihttp://hdl.handle.net/10541/115182
dc.description.abstractTwo hundred and ninety-six consecutive patients under the age of 70 years and having Stage III carcinoma of the cervix were randomised to receive one of two radical radiotherapy techniques. The first was a small-field, wedged, inhomogeneous 3-week X-ray treatment, followed by two radical radium insertions delivering 80% of a radical intracavity dose. The second was a 4-week homogeneous, large-field X-ray technique, supplemented by a single intracavitary insertion giving 50% of a radical intracavitary dose. Mature 5-year survival rates for the two techniques were 38.6% and 40.3% respectively (p = 0.76). Corrected 5-year results were 44.5% and 45% (p = 0.8). The time to pelvic recurrence and the sites of pelvic recurrence were not significantly different. The rate of major morbidity was eight out of 148 in the first group and five out of 148 in the second. This large, prospective, randomised trial failed to identify any significant advantage to two conceptually different techniques which explored different volumes, fractionation and balance between X-ray therapy and intracavitary therapy. The overall results remain very satisfactory when compared with recently published European results.
dc.language.isoenen
dc.subjectCancer Stagingen
dc.subjectUterine Cervical Canceren
dc.subject.meshAged
dc.subject.meshBrachytherapy
dc.subject.meshClinical Trials as Topic
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshNeoplasm Staging
dc.subject.meshProspective Studies
dc.subject.meshRandom Allocation
dc.subject.meshUterine Cervical Neoplasms
dc.titleA clinical trial of two conceptually different radical radiotherapy treatments in stage III carcinoma of the cervix.en
dc.typeArticleen
dc.identifier.eissn1365-229X
dc.contributor.departmentDepartment of Radiotherapy, Christie Hospital and Holt Radium Institute, Manchester M20 9BX, UKen
dc.identifier.journalClinical Radiologyen
html.description.abstractTwo hundred and ninety-six consecutive patients under the age of 70 years and having Stage III carcinoma of the cervix were randomised to receive one of two radical radiotherapy techniques. The first was a small-field, wedged, inhomogeneous 3-week X-ray treatment, followed by two radical radium insertions delivering 80% of a radical intracavity dose. The second was a 4-week homogeneous, large-field X-ray technique, supplemented by a single intracavitary insertion giving 50% of a radical intracavitary dose. Mature 5-year survival rates for the two techniques were 38.6% and 40.3% respectively (p = 0.76). Corrected 5-year results were 44.5% and 45% (p = 0.8). The time to pelvic recurrence and the sites of pelvic recurrence were not significantly different. The rate of major morbidity was eight out of 148 in the first group and five out of 148 in the second. This large, prospective, randomised trial failed to identify any significant advantage to two conceptually different techniques which explored different volumes, fractionation and balance between X-ray therapy and intracavitary therapy. The overall results remain very satisfactory when compared with recently published European results.


Files in this item

This item appears in the following Collection(s)

Show simple item record